Our study investigated for the first time, to our knowledge, whether PTH and calprotectin are present in the amniotic fluid from the early second trimester of pregnancy and, additionally, whether there is any correlation between these two mediators and fetal growth disorders such as SGA or LGA compared to AGA (appropriate for gestational age) fetuses. The gene discussed is PTH; the disease is hereditary endocrine growth disease.